Significant nationwide investment in precision medicine

16 September, 2021 | Press release

The Swedish national infrastructure Genomic Medicine Sweden (GMS) will receive an additional SEK 220 million investment. The investment will facilitate the continued introduction of precision medicine into Swedish healthcare, so that every individual in Sweden has...

Precision medicine new opportunity for complex diseases

5 July, 2021 | News

New review article looks at readiness prior to the implementation of genomics-based precision medicine in complex diseases. The extensive work has been led by researchers at Karolinska Institutet and Lund University and has been carried out together with some 30...

Common lessons learned from the start-up of precision medicine initiatives

30 June, 2021 | News

Over recent years, a large number of national and regional initiatives in the field of precision medicine have been established in Europe. In an overview published in Seminars in Cancer Biology, Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM)...

GMS’s ambitions for the next 10 years

28 January, 2021 | News

Genomic Medicine Sweden (GMS) highlights vital aspects for the successful introduction of precision medicine into Swedish healthcare in its Strategy Plan 2021–2030. In Strategy Plan 2021–2030, GMS presents its ambitions for the introduction of precision medicine into...

GMS receives SEK 16.5 million for investment in childhood cancer and cancer that affects women

22 December, 2020 | News

The government announced today that the National Board of Health and Welfare will be commissioned to pay SEK 16.5 million to GMS to pilots in genetic and molecular diagnostics. Of this, SEK 8.5 million will go to pilot projects that deal with childhood cancer and the...

Report from the first meeting with the GMS Scientific Advisory Board

18 December, 2020 | News

The Scientific Advisory Board, SAB, is impressive about GMS ‘rapid development and the enormous work that GMS has accomplished. But emphasizes the importance of a formal national leadership structure and lists five important strategic recommendations for further...

Sweden’s innovation agency Vinnova increases funding to support GMS and the implementation of precision medicine in healthcare

2 July, 2020 | News

Sweden’s innovation agency Vinnova extends the funding of the national initiative Genomic Medicine Sweden (GMS) with an additional 36 MSEK in order to enable individualized healthcare solutions. The new technology allows for more patients to receive the appropriate...

Bettina Lundgren new member of GMS Scientific Advisory Board

10 June, 2020 | News

Bettina Lundgren, CEO of the Danish National Genome Center, has recently joined the GMS Scientific Advisory Board. “We welcome Bettina Lundgren to our Scientific Advisory Board and look forward to sharing experiences between the Swedish and Danish initiatives”, said...

GMS and Illumina collaborate to develop whole-genome sequencing for patients with acute leukemia

28 May, 2020 | Press

A new study has been initiated to evaluate whole-genome and RNA-sequencing as a first line diagnostic approach for patients in Sweden with acute leukemia. The study will assess the potential of these sequencing approaches to replace current diagnostic methods in order...

Expanded testing of Covid-19 in cooperation between Sweden’s university hospitals, SciLifeLab, and Karolinska Institutet

2 April, 2020 | News

A collaboration has been initiated between Sweden’s clinical microbiology laboratories, SciLifeLab, Karolinska Institutet (KI) and the Public Health Agency of Sweden, to increase possibilities for testing of Covid-19 in Sweden. A significant grant from Knut and Alice...